Brief: Lineage Cell Therapeutics Q2 Income From Operations USD -8.923 Million
BRIEF-Lineage Cell Therapeutics Q2 Income From Operations USD -8.923 Million Aug 06 (Reuters) - Lineage Cell Therapeutics Q2 operating expenses USD 9.992 million.
- Q2 net income USD 1.544 million
Recent news on Lineage Cell Therapeutics
See all newsLineage Cell Therapeutics Q2 revenue falls but posts profit
Brief: Lineage Cell Therapeutics Q2 Income From Operations USD -8.923 Million
Lineage Cell Therapeutics Q1 net loss widens as expenses rise
Lineage Cell Q4 revenue rises on Genentech collaboration
Brief: Lineage Cell Therapeutics FY Income From Operations USD -36.619 Million